AI assistance significantly increases radiologists' sensitivity and efficiency in detecting early lung cancer on chest CT scans.
Key Details
- 1Study published in Journal of the American College of Radiology (January 2024).
- 2Researchers from Georgetown University evaluated 16 radiologists interpreting 340 low-dose chest CTs, both with and without AI assistance, spaced by a 1-month interval.
- 3Overall detection LROC AUC increased from 0.65 (without AI) to 0.76 (with AI).
- 4Sensitivity rose from 0.59 to 0.73 (a 24.3% increase), with minimal impact on specificity (0.92 vs. 0.91).
- 5Average interpretation time dropped by 12.9% (133s to 115.9s).
- 6AI benefit was largest in screening scenarios and for small nodules or cancers <10mm.
Why It Matters
This study provides strong evidence that integrating AI into chest CT workflows improves both the accuracy and efficiency of lung cancer screening, especially for challenging small lesions. Adoption of such AI tools could lead to earlier detection and better patient outcomes.
Source
AuntMinnie
Related News
•Radiology Business
AI Analyzes Mammograms to Assess Post-Surgery Breast Cancer Recurrence Risk
A new AI tool predicts likelihood of breast cancer recurrence after surgery using pre-operative mammograms.
•Radiology Business
AI Model Aims to Detect Placenta Accreta Earlier in Pregnancy
Researchers present a new AI model to help diagnose placenta accreta spectrum before delivery.
•Radiology Business
FDA Clears Median's Eyonis AI for CT Lung Cancer Screening
Median Technologies' Eyonis LCS, an AI tool for low-dose CT lung cancer screening, receives FDA clearance.